drugset / Trial / NCT07442071

Impact of Low Dose Epinephrine in the Management of Out-of-hospital Cardiac Arrest on Neurological Outcome

NCT07442071

Phase 3 Not yet recruiting 4336 enrolled Central Hospital, Nancy, France
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This study will test whether a lower dose of epinephrine (0.5 mg) given during emergency treatment for out-of-hospital cardiac arrest helps more patients survive with good brain function, compared to the standard dose (1 mg). Adults who experience cardiac arrest outside the hospital and are treated by emergency medical teams will be randomly assigned to receive either the low dose or the standard dose of epinephrine. The study will compare survival and neurological outcomes between the two groups over 28 days.

Timeline

Start
2026-06
Primary completion
2030-07
Completion
2030-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Epinephrine Other / unclassified 0.5 mg Intravenous
Subject Epinephrine Other / unclassified 1 mg Intravenous

Indications